The trademark OPTINEX was filed by Santen Pharmaceutical Co., Ltd., a corporation established under the laws of Japan (the "Applicant"). The application was published for oppositions on December 17, 2007, and received one opposition filed on March 17, 2008 by BRITANNIA PHARMACEUTICALS LIMITED on Likelihood of confusion. the opponent was represented by VENNER SHIPLEY LLP and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued March 17, 2008
The application was filed in Finnish, and Finnish was also language of all opposition proceedings (English was selected as the second language).
The renewal of the trademark was recorded by the office on January 19, 2017.
Change of name and address of the trademark registration was recorded on January 27, 2015. Appointment and Replacement of representative of the trademark registration was recorded on July 14, 2015. Change of name and professional address of the trademark registration was recorded on January 31, 2019. Change of name and professional address of the trademark registration was recorded on January 30, 2020. Change of name and address of the trademark registration was recorded on March 25, 2020.